Investor Presentaiton

Projected Opex and Capex In $M, Non-GAAP % of Total Revenues Average # NM NM 406.8% 129.8% 48.1% 22.6% 264 357 420 477 535 595 of FTEs 131 114 16 103 15 95 28 90 14 11 19 11 14 11 68 9 9698 71 73 53 75 75 80 87 80 2020 2021 2022 2023 2024 2025 ■ R&D ■ S&M ■G&A Select Cash Flow Items Capex NRE¹ (4) 1 (6) 3 (8) 4 Note: Preliminary management projections. 1 NRE cash inflows are recognized as deferred revenues over the lifetime of the different programs. INNOVIZ™ TECHNOLOGIES (14) 7 (19) (29) 8 9 Innoviz Technologies Ltd. 2020 All Rights Reserved - Proprietary & Confidential. No part of this document may be reproduced or disclosed in any manner. 35 35

View entire presentation